Copyright
©The Author(s) 2004.
World J Gastroenterol. Feb 15, 2004; 10(4): 476-480
Published online Feb 15, 2004. doi: 10.3748/wjg.v10.i4.476
Published online Feb 15, 2004. doi: 10.3748/wjg.v10.i4.476
Table 1 Expression of Egr-1, c-fos and cyclin D1 mRNAs and their proteins in esophageal precancerous lesions and cancer tissues
| Groups | n | Egr-1 positivity | c-fos positivity | cyclin D1 positivity | |||
| ISH(%) | IHC (%) | ISH(%) | IHC(%) | ISH(%) | IHC(%) | ||
| Normal epithelia | 42 | 13 (31.0) | 3 (7.1) | 2 (4.8) | 1 (2.4) | 2 (4.8) | 0 (0.0) |
| Simple hyperplasia | 54 | 18 (33.3) | 8 (14.8) | 3 (5.6) | 3 (5.6) | 5 (9.3) | 3 (5.6) |
| Dysplasia | 44 | 27 (61.4) | 21 (47.7) | 30 (68.2) | 29 (65.9) | 6 (13.6) | 6 (13.6) |
| Carcinoma in situ | 2 | 1 (50.0) | 1 (50.0) | 1 (50.0) | 1 (50.0) | 0 (0.0) | 0 (0.0) |
| Invasive carcinoma | 68 | 12 (17.6) | 9 (13.2) | 35 (51.5) | 36 (52.9) | 35 (51.5) | 33 (48.5) |
- Citation: Wu MY, Zhuang CX, Yang HX, Liang YR. Expression of Egr-1, c-fos and cyclin D1 in esophageal cancer and its precursors: An immunohistochemical and in situ hybridization study. World J Gastroenterol 2004; 10(4): 476-480
- URL: https://www.wjgnet.com/1007-9327/full/v10/i4/476.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i4.476